Amyotrophic Lateral Sclerosis (ALS) Market Report

China Amyotrophic Lateral Sclerosis (ALS) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 08, 2023
  • PAGES：211
  • REPORT CODE：GMM1782980
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Amyotrophic Lateral Sclerosis (ALS) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sun Pharma

    • Mitsubishi Tanabe Pharma

    • Glemark Generics

    • Lunan Pharma

    • Sanofi

    • Covis Pharma

    • Mylan Pharma

    By Type:

    • Edaravone (Radicava)

    • Riluzole

    • Other

    By Application:

    • Hospital

    • Other

    • Drugs Store

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Amyotrophic Lateral Sclerosis (ALS) Market Overview 2018-2029

    • 1.1 China Amyotrophic Lateral Sclerosis (ALS) Industry Development Overview

    • 1.2 China Amyotrophic Lateral Sclerosis (ALS) Industry Development History

    • 1.3 China Amyotrophic Lateral Sclerosis (ALS) Industry Market Size (2018-2029)

    • 1.4 China Amyotrophic Lateral Sclerosis (ALS) Market Analysis by Type from Production Side

      • 1.4.1 China Amyotrophic Lateral Sclerosis (ALS) Production Volume, Production Value and Growth Rate of Edaravone (Radicava) (2018-2029)

      • 1.4.2 China Amyotrophic Lateral Sclerosis (ALS) Production Volume, Production Value and Growth Rate of Riluzole (2018-2029)

      • 1.4.3 China Amyotrophic Lateral Sclerosis (ALS) Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • 1.5 China Amyotrophic Lateral Sclerosis (ALS) Market Analysis by Application from Consumption End

      • 1.5.1 China Amyotrophic Lateral Sclerosis (ALS) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Amyotrophic Lateral Sclerosis (ALS) Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China Amyotrophic Lateral Sclerosis (ALS) Sales Volume, Sales Value and Growth Rate of Drugs Store (2018-2029)

    • 1.6 China Amyotrophic Lateral Sclerosis (ALS) Market Analysis by Region

      • 1.6.1 North China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Amyotrophic Lateral Sclerosis (ALS) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Amyotrophic Lateral Sclerosis (ALS) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Amyotrophic Lateral Sclerosis (ALS) Market Status and Competition Analysis in 2023

      • 2.2.3 China Amyotrophic Lateral Sclerosis (ALS) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Amyotrophic Lateral Sclerosis (ALS) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Amyotrophic Lateral Sclerosis (ALS) Industry Development

    Chapter 3 Amyotrophic Lateral Sclerosis (ALS)Industry Chain Analysis

    • 3.1 Amyotrophic Lateral Sclerosis (ALS) Industry Chain

    • 3.2 Amyotrophic Lateral Sclerosis (ALS) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Amyotrophic Lateral Sclerosis (ALS) Market

    • 3.3 Amyotrophic Lateral Sclerosis (ALS) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Amyotrophic Lateral Sclerosis (ALS) Market

    Chapter 4 China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 4.1 China Amyotrophic Lateral Sclerosis (ALS) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Amyotrophic Lateral Sclerosis (ALS) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate, by Type

      • 4.5.1 China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate of Edaravone (Radicava)

      • 4.5.2 China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate of Riluzole

      • 4.5.3 China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate of Other

    Chapter 5 China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Amyotrophic Lateral Sclerosis (ALS) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate, by Application

      • 5.5.1 China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Hospital

      • 5.5.2 China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other

      • 5.5.3 China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Drugs Store

    Chapter 6 China Amyotrophic Lateral Sclerosis (ALS) Market, by Region

    • 6.1 China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Production Value, by Region

    • 6.2 China Amyotrophic Lateral Sclerosis (ALS) Sales Volume and Sales Value, by Region

    Chapter 7 North China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 7.1 North China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 7.2 North China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 8 Central China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 8.1 Central China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 8.2 Central China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 9 South China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 9.1 South China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 9.2 South China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 10 East China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 10.1 East China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 10.2 East China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 11 Northeast China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 11.1 Northeast China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 11.2 Northeast China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 12 Southwest China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 12.1 Southwest China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 12.2 Southwest China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 13 Northwest China Amyotrophic Lateral Sclerosis (ALS) Market Analysis

    • 13.1 Northwest China Amyotrophic Lateral Sclerosis (ALS) Market, by Type

    • 13.2 Northwest China Amyotrophic Lateral Sclerosis (ALS) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sun Pharma

        • 14.1.1 Sun Pharma Company Profile

        • 14.1.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Mitsubishi Tanabe Pharma

        • 14.2.1 Mitsubishi Tanabe Pharma Company Profile

        • 14.2.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Glemark Generics

        • 14.3.1 Glemark Generics Company Profile

        • 14.3.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Lunan Pharma

        • 14.4.1 Lunan Pharma Company Profile

        • 14.4.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sanofi

        • 14.5.1 Sanofi Company Profile

        • 14.5.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Covis Pharma

        • 14.6.1 Covis Pharma Company Profile

        • 14.6.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Mylan Pharma

        • 14.7.1 Mylan Pharma Company Profile

        • 14.7.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Amyotrophic Lateral Sclerosis (ALS) Industry Research Conclusions

    • 15.2 Amyotrophic Lateral Sclerosis (ALS) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Industry Market Size (2018-2029)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume, Production Value and Growth Rate of Edaravone (Radicava) (2018-2029)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume, Production Value and Growth Rate of Riluzole (2018-2029)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Sales Volume, Sales Value and Growth Rate of Drugs Store (2018-2029)

    • Figure North China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure Central China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure South China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure East China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2018-2029

    • Figure Amyotrophic Lateral Sclerosis (ALS) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2018

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2023

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate of Edaravone (Radicava) (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate of Riluzole (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2018

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2023

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Total Market Size and Growth Rate from Consumption End

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Drugs Store (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Region (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Production Value by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Production Value Share by Region (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Production Value Share by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Region (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Sales Value by Region (2018-2023)

    • Table China Amyotrophic Lateral Sclerosis (ALS) Sales Value Share by Region (2018-2023)

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Sales Value Share by Region (2018-2023)

    • Table North China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table North China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure North China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table North China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table North China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure North China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table Central China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table Central China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure Central China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table Central China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table Central China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure Central China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table South China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table South China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure South China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table South China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table South China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure South China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table East China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table East China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure East China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table East China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table East China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure East China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table Northeast China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table Northeast China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table Northeast China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table Southwest China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table Southwest China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table Southwest China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Amyotrophic Lateral Sclerosis (ALS) Production Volume by Type (2018-2023)

    • Table Northwest China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Amyotrophic Lateral Sclerosis (ALS) Production Volume Share by Type (2018-2023)

    • Table Northwest China Amyotrophic Lateral Sclerosis (ALS) Sales Volume by Application (2018-2023)

    • Table Northwest China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Amyotrophic Lateral Sclerosis (ALS) Sales Volume Share by Application (2018-2023)

    • Table Sun Pharma Company Profile

    • Table Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)

    • Table Mitsubishi Tanabe Pharma Company Profile

    • Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)

    • Table Glemark Generics Company Profile

    • Table Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)

    • Table Lunan Pharma Company Profile

    • Table Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)

    • Table Covis Pharma Company Profile

    • Table Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)

    • Table Mylan Pharma Company Profile

    • Table Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US